{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:13:59Z","timestamp":1793164439059,"version":"4.5.0"},"reference-count":17,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cRevert Onlus\u201d association"},{"name":"\u201cIRCCS Casa Sollievo della Sofferenza\u201d research hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Translation of cell therapies into clinical practice requires the adoption of robust production protocols in order to optimize and standardize the manufacture and cryopreservation of cells, in compliance with good manufacturing practice regulations. Between 2012 and 2020, we conducted two phase I clinical trials (EudraCT 2009-014484-39, EudraCT 2015-004855-37) on amyotrophic lateral sclerosis secondary progressive multiple sclerosis patients, respectively, treating them with human neural stem cells. Our production process of a hNSC-based medicinal product is the first to use brain tissue samples extracted from fetuses that died in spontaneous abortion or miscarriage. It consists of selection, isolation and expansion of hNSCs and ends with the final pharmaceutical formulation tailored to a specific patient, in compliance with the approved clinical protocol. The cells used in these clinical trials were analyzed in order to confirm their microbiological safety; each batch was also tested to assess identity, potency and safety through morphological and functional assays. Preclinical, clinical and in vitro nonclinical data have proved that our cells are safe and stable, and that the production process can provide a high level of reproducibility of the cultures. Here, we describe the quality control strategy for the characterization of the hNSCs used in the above-mentioned clinical trials.<\/jats:p>","DOI":"10.3390\/ijms232113425","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T03:53:07Z","timestamp":1667447587000},"page":"13425","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5721-0410","authenticated-orcid":false,"given":"Daniela Celeste","family":"Profico","sequence":"first","affiliation":[{"name":"Unit\u00e0 Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-9849","authenticated-orcid":false,"given":"Maurizio","family":"Gelati","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"},{"name":"Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Dipartimento di Biotecnologie e Bioscienze, Universit\u00e0 Milano Bicocca, 20126 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Sgaravizzi","sequence":"additional","affiliation":[{"name":"Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ricciolini","sequence":"additional","affiliation":[{"name":"Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Projetti Pensi","sequence":"additional","affiliation":[{"name":"Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Muzi","sequence":"additional","affiliation":[{"name":"Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cajola","sequence":"additional","affiliation":[{"name":"Dipartimento di Biotecnologie e Bioscienze, Universit\u00e0 Milano Bicocca, 20126 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Copetti","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Biostatistica, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-123X","authenticated-orcid":false,"given":"Emilio","family":"Ciusani","sequence":"additional","affiliation":[{"name":"Laboratorio Analisi, Instituto Nazionale Neurologico C. Besta, 20133 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7669-4457","authenticated-orcid":false,"given":"Raffaele","family":"Pugliese","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Ingegneria Tissutale, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-5853","authenticated-orcid":false,"given":"Fabrizio","family":"Gelain","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Ingegneria Tissutale, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Luigi","family":"Vescovi","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neulet.2008.03.097","article-title":"Regeneration and repair in multiple sclerosis: The role of cell transplantation","volume":"456","author":"Pluchino","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0959-4388(94)90019-1","article-title":"Clinical application of cell transplantation and neurotrophic factors in CNS disorders","volume":"4","author":"Lindvall","year":"1994","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/BF00939243","article-title":"Clinical application of neuronal grafts in Parkinson\u2019s disease","volume":"242","author":"Lindvall","year":"1994","journal-title":"J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of Embryonic Dopamine Neurons for Severe Parkinson\u2019s Disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/brain\/awh510","article-title":"Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease","volume":"128","author":"Mendez","year":"2005","journal-title":"Brain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/acn3.567","article-title":"Long-term Phase 1\/2 intraspinal stem cell transplantation outcomes in ALS","volume":"5","author":"Goutman","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_7","first-page":"13","article-title":"Human neural stem cell transplantation in ALS: Initial results from a phase I trial","volume":"27","author":"Mazzini","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/sctm.18-0154","article-title":"Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome","volume":"8","author":"Mazzini","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2017.08.017","article-title":"Stem cell transplantation for Huntington\u2019s diseases","volume":"133","author":"Choi","year":"2018","journal-title":"Methods"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"146615","DOI":"10.1016\/j.brainres.2019.146615","article-title":"The neural stem cell secretome and its role in brain repair","volume":"1729","author":"Willis","year":"2019","journal-title":"Brain Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2017.02.006","article-title":"Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support","volume":"106","author":"Marsh","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","article-title":"Generation of Neurons and Astrocytes from Isolated Cells of the Adult Mammalian Central Nervous System","volume":"255","author":"Reynolds","year":"1992","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1523\/JNEUROSCI.19-09-03287.1999","article-title":"Epidermal and Fibroblast Growth Factors Behave as Mitogenic Regulators for a Single Multipotent Stem Cell-Like Population from the Subventricular Region of the Adult Mouse Forebrain","volume":"19","author":"Gritti","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1523\/JNEUROSCI.12-11-04565.1992","article-title":"A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes","volume":"12","author":"Reynolds","year":"1992","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/neu.1999.16.689","article-title":"Isolation and Intracerebral Grafting of Nontransformed Multipotential Embryonic Human CNS Stem Cells","volume":"16","author":"Vescovi","year":"1999","journal-title":"J. Neurotrauma"},{"key":"ref_16","first-page":"65","article-title":"Culturing and Expansion of \u201cClinical Grade\u201d Precursors Cells from the Fetal Human Central Nervous System","volume":"1059","author":"Gelati","year":"2013","journal-title":"Adv. Struct. Saf. Stud."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41419-019-1582-5","article-title":"Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats","volume":"10","author":"Zalfa","year":"2019","journal-title":"Cell Death Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13425\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:43Z","timestamp":1760144983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":17,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232113425"],"URL":"https:\/\/doi.org\/10.3390\/ijms232113425","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}